Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal
Biological psychiatry
Date
2015-10-15
Source
PubMed
DOI
10.1016/j.biopsych.2014.04.010
PubMed
24882567
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:54:14 UTC
Metadata last checked
2026-08-09 08:28:27 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Citation graph

0 referenced DOIs found in stored source metadata. 19 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Cannabis and Psilocybin Co-use: Associations with Stress and Well-being2026-10-13Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms2026-07-01Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants2026-07-01Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developments2026-06-12Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies2026-03-19Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy2026-03-01Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung2025-05-01Psilocybin - A Drug to be Considered for the Treatment of Anxiety and Depression in Cancer Patients2024-07-31PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin2024-07-24The potential of psilocybin use to enhance well-being in healthy individuals - A scoping review2023-11-29Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocol2023-10-25Experiences With Sacred Mushrooms and Psilocybin In Dialogue: Transdisciplinary Interpretations Of The “Velada”2022-08-09Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin2022-06-01New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances2021-09-17Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa2021-06-24Psychedelics as a Training Experience for Psychedelic Therapists: Drawing on History to Inform Current Practice2021-06-23Preclinical Behavioral Assessment of Chronic, Intermittent Low-Dose Psilocybin in Rodent Models of Depression and Anxiety2021-01-01A potential role for psilocybin in the treatment of obsessive-compulsive disorder2020-06-01Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism2016-10-16

Related papers

No close related records were found yet.